- ►annals.org [PDF] J Arnlov, MJ Pencina, S Amin, BH Nam, EJ … - Annals of internal medicine, 2006 - Am Coll Physicians JohanArnlöv, MD, PhD; Michael J. Pencina, PhD; Shreyasee Amin, MD; Byung-Ho
Nam, PhD; Emelia J. Benjamin, MD, ScM; Joanne M. Murabito, MD, ScM; Thomas J.
Wang, MD; Philip E. Knapp, MD; Ralph B. D'Agostino Sr., PhD; Shalendar ... Cited by 54 - Related articles - All 4 versions
A Table - Ann Intern Med, 2006 - assets0.pubget.com Johan ¨Arnlöv, MD, PhD; Michael J. Pencina, PhD; Shreyasee Amin, MD; Byung-Ho
Nam, PhD; Emelia J. Benjamin, MD, ScM; Joanne M. Murabito, MD, ScM; Thomas J.
Wang, MD; Philip E. Knapp, MD; Ralph B. D'Agostino Sr., PhD; Shalendar ... Related articles - View as HTML
- ►endojournals.org A Tivesten, J Hulthe, K Wallenfeldt, J … - Journal of Clinical Endocrinology & Metabolism, 2006 - Endocrine Soc Context: Estrogen treatment of men with prostate cancer is associated with
increased cardiovascular morbidity and mortality; however, the role of
endogenous estrogen levels for atherosclerotic disease in men is unknown. Cited by 21 - Related articles - BL Direct - All 4 versions
- ►onlinejacc.org Å Tivesten, D Mellström, H Jutberger, B … - Journal of the American College of Cardiology, 2007 - Elsevier This study sought to determine whether serum levels of testosterone and
estradiol associate with lower extremity peripheral arterial disease (PAD) in a
large population-based cohort of elderly men. Cited by 20 - Related articles - BL Direct - All 15 versions
- ►onlinejacc.org J Mäkinen, MJ Järvisalo, P Pöllänen, A … - Journal of the American College of Cardiology, 2005 - Elsevier We studied 239 40- to 70-year-old men (mean ± SD: 57 ± 8 years) who
participated in the Turku Aging Male Study and underwent serum lipid and sex
hormone measurements. Ninety-nine men (age 58 ± 7 years) were considered ... Cited by 48 - Related articles - All 23 versions
- ►ahajournals.org PA Komesaroff, M Fullerton, MD Esler, A Dart, … - Hypertension, 2001 - Am Heart Assoc Abstract—— It is widely accepted that in women, estrogens provide protection
against the development of cardiovascular disease. However, the cardiovascular
role of estrogens in men remains uncertain, despite preliminary evidence ... Cited by 36 - Related articles - BL Direct - All 8 versions
RD Abbott, LJ Launer, BL Rodriguez, GW Ross … - Neurology, 2007 - AAN Enterprises From the Division of Biostatistics and Epidemiology (RDA), University of
Virginia School of Medicine, Charlottesville; Department of Health Science
(RDA), Shiga University of Medical Science, Otsu, Japan; Laboratory of ... Cited by 13 - Related articles - BL Direct - All 6 versions
- ►endojournals.org M Muller, YT van der Schouw, JHH Thijssen, … - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc Unlike women, men do not experience an abrupt reduction in endogenous sex
hormone production. It has, however, become clear that an age-associated
decrease in the levels of (bioactive) sex hormones does occur. Whether ... Cited by 62 - Related articles - All 5 versions
- ►revespcardiol.org NK Wenger - REVISTA ESPANOLA DE CARDIOLOGIA, 2006 - elsevier.es The Heart and Estrogen Replacement Study (HERS) 2 randomized 2763 menopausal
women, mean age 67 years, with established CHD to conjugated equine estrogen
plus medroxyprogesterone acetate daily compared with placebo and followed ... Cited by 4 - Related articles - BL Direct - All 5 versions
BG Choi, MA McLaughlin - Endocrinology and metabolism clinics of North America, 2007 - Elsevier Coronary artery disease (CAD) has long been recognized as the leading cause of
morbidity and mortality in men [1]. Since 1950, modern medical management of CAD
has resulted in a 70% reduction in mortality attributable to CAD (Fig. 1) ... Cited by 22 - Related articles - All 27 versions
